After months of biotech companies avoiding public markets like the plague, LB Pharmaceuticals just broke the drought with a $285 million initial public offering that
AbbVie just pulled off one of the most successful patent defense strategies in recent pharmaceutical history. By settling with all generic challengers to its blockbuster
The pharmaceutical industry’s marketing playbook is about to get a major rewrite. The FDA has announced an aggressive campaign against misleading drug advertisements, signaling the
The FDA just delivered hope to families dealing with one of childhood’s most challenging rare diseases. In a groundbreaking decision, the agency has expanded access
August 2025 will be remembered as a watershed moment for the biotechnology industry, with over 20 companies announcing significant layoffs as the sector undergoes its
In a dramatic reversal that highlights the delicate balance of vaccine development, the FDA has suspended use of the world’s first chikungunya vaccine after recipients
The UK’s National Institute for Health and Care Excellence (NICE) has proposed the most significant overhaul of type 2 diabetes treatment in over a decade,
In a landmark decision that could transform treatment for hundreds of thousands of Americans, the FDA has approved Brinsupri (insmedpirdine) as the first-ever medication specifically
A striking disconnect has emerged in healthcare’s artificial intelligence adoption, with new survey data revealing that while 99% of healthcare organizations are actively using generative
The digital health sector is experiencing a notable resurgence, with U.S. startups raising $6.4 billion in the first half of 2025, marking a modest but
